Verrucous endocarditis secondary to Saccharomyces cerevisiae. A case report Endocarditis verrucosa secundaria a Saccharomyces cerevisiae. Caso clínico.
Author
dc.contributor.author
Ruiz-Esquide, Fernando
Author
dc.contributor.author
Díaz, María Cristina
Author
dc.contributor.author
Wu Hupat, Elba
Author
dc.contributor.author
Silva, Víctor
Admission date
dc.date.accessioned
2019-01-29T17:51:47Z
Available date
dc.date.available
2019-01-29T17:51:47Z
Publication date
dc.date.issued
2002
Cita de ítem
dc.identifier.citation
Revista medica de Chile, Volumen 130, Issue 10, 2018, Pages 1165-1169
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/163569
Abstract
dc.description.abstract
We report a preterm infant with 30 weeks of gestation, that received broad spectrum antimicrobials during the first days of life. At nine days of life, the infant appeared with abdominal distension and hematochezia. A systolic murmur with changing auscultatory features also appeared. An echocardiography showed an atrial vegetation. A yeast, that was identified as the emergent pathogen Saccharomyces cerevisiae appeared in two blood cultures. Treatment with amphotericin B was started, the dose was adjusted calculating the minimal inhibitory concentration of amphotericin B, and measuring plasma levels of the antimicrobial. Therefore the minimal effective dose was prescribed, avoiding its deleterious effects. After 14 days of antifungal therapy, a new echocardiography showed a reduction in the size of the atrial vegetation. At 35 days, it disappeared and amphotericin B was discontinued. On the outpatient follow up, the infant has shown a normal growth and a normal cardiac auscultation.
Verrucous endocarditis secondary to Saccharomyces cerevisiae. A case report Endocarditis verrucosa secundaria a Saccharomyces cerevisiae. Caso clínico.